ArticleNPJ science of food2025
Improved adhesion and function of Pediococcus pentosaceus Li05 for acute colitis through surface modification.
Article in NPJ science of food, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Integrated Multi-Omics Analysis Explores the Protective Effects and Potential Mechanisms ofBiomolecules · 2026Article
- The therapeutic potential ofFrontiers in microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Probiotics have been widely used as an adjuvant therapy to treat or prevent various diseases. However, therapeutic effect is usually contingent on the ability of the probiotic cells to adhere to and colonize the gastrointestinal tract. Pediococcus pentosaceus Li05 has previously been shown anti-inflammatory effect, however, its mucoadhesive ability limited further application. In this study, MUC2 antibody was used as an adhesin and conjugated to the surface of Li05 (M-Li05) and our results demonstrated that the adhesion and colonization resistance were significantly improved in vitro. Moreover, competitive adhesion experiments in mice demonstrated that Li05 outcompeted Citrobacter rodentium; an effect even more pronounced with M-Li05. The study also showed that M-Li05 significantly reduced colonic histological injury, alleviated inflammation and decreased pathogens colonization in the C. rodentium-infected and DSS-induced colitis mouse model. In summary, the results demonstrated that M-Li05 showed promise for future application as a therapeutic strategy for colitis.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.